These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Intravitreal injection of bevacizumab combined with verteporfin photodynamic therapy for choroidal neovascularization in age-related macular degeneration. Smith BT; Dhalla MS; Shah GK; Blinder KJ; Ryan EH; Mittra RA Retina; 2008 May; 28(5):675-81. PubMed ID: 18463509 [TBL] [Abstract][Full Text] [Related]
9. Triple therapy for neovascular age-related macular degeneration using single-session photodynamic therapy combined with intravitreal bevacizumab and triamcinolone. Yip PP; Woo CF; Tang HH; Ho CK Br J Ophthalmol; 2009 Jun; 93(6):754-8. PubMed ID: 19273471 [TBL] [Abstract][Full Text] [Related]
10. Triple therapy for choroidal neovascularization due to age-related macular degeneration: verteporfin PDT, bevacizumab, and dexamethasone. Augustin AJ; Puls S; Offermann I Retina; 2007 Feb; 27(2):133-40. PubMed ID: 17290193 [TBL] [Abstract][Full Text] [Related]
11. Verteporfin photodynamic therapy combined with intravitreal bevacizumab for neovascular age-related macular degeneration. Kaiser PK; ; Boyer DS; Garcia R; Hao Y; Hughes MS; Jabbour NM; Kaiser PK; Mieler W; Slakter JS; Samuel M; Tolentino MJ; Roth D; Sheidow T; Strong HA Ophthalmology; 2009 Apr; 116(4):747-55, 755.e1. PubMed ID: 19243834 [TBL] [Abstract][Full Text] [Related]
13. Intravitreal bevacizumab for previously treated choroidal neovascularization from age-related macular degeneration. Goff MJ; Johnson RN; McDonald HR; Ai E; Jumper JM; Fu A Retina; 2007; 27(4):432-8. PubMed ID: 17420694 [TBL] [Abstract][Full Text] [Related]
14. A prospective study on different methods for the treatment of choroidal neovascularization. The efficacy of verteporfin photodynamic therapy, intravitreal bevacizumab and transpupillary thermotherapy in patients with neovascular age-related macular degeneration. Nowak MS; Jurowski P; Grzybowski A; Goś R; Pastuszka M; Kapica A; Śmigielski J Med Sci Monit; 2012 Jun; 18(6):CR374-80. PubMed ID: 22648253 [TBL] [Abstract][Full Text] [Related]
15. Intravitreal bevacizumab combined with photodynamic therapy for the treatment of occult choroidal neovascularization associated with serous pigment epithelium detachment in age-related macular degeneration. Ladas ID; Kotsolis AI; Papakostas TD; Rouvas AA; Karagiannis DA; Vergados I Retina; 2007 Sep; 27(7):891-6. PubMed ID: 17891013 [TBL] [Abstract][Full Text] [Related]
16. Pilot study of safety and effect of combined intravitreal bevacizumab and methotrexate for neovascular age-related macular degeneration. Soheilian M; Movaseghi M; Ramezani A; Peyman GA Eur J Ophthalmol; 2011; 21(1):77-82. PubMed ID: 20872362 [TBL] [Abstract][Full Text] [Related]
17. Combined therapy (intravitreal bevacizumab plus verteporfin photodynamic therapy) versus intravitreal bevacizumab monotherapy for choroidal neovascularization due to age-related macular degeneration: a 1-year follow-up study. Saviano S; Leon PE; Mangogna A; Tognetto D Digit J Ophthalmol; 2016; 22(2):46-53. PubMed ID: 27582675 [TBL] [Abstract][Full Text] [Related]
18. Intravitreal bevacizumab for the management of choroidal neovascularization in age-related macular degeneration. Bashshur ZF; Bazarbachi A; Schakal A; Haddad ZA; El Haibi CP; Noureddin BN Am J Ophthalmol; 2006 Jul; 142(1):1-9. PubMed ID: 16815245 [TBL] [Abstract][Full Text] [Related]
19. Treatment of choroidal neovascularization using intravitreal bevacizumab. Pedersen R; Soliman W; Lund-Andersen H; Larsen M Acta Ophthalmol Scand; 2007 Aug; 85(5):526-33. PubMed ID: 17511757 [TBL] [Abstract][Full Text] [Related]
20. Anti-vascular endothelial growth factor monotherapy versus combination treatment with photodynamic therapy for subfoveal choroidal neovascularization secondary to causes other than age-related macular degeneration. Chen L; Miller JW; Vavvas D; Kim IK Retina; 2011 Nov; 31(10):2078-83. PubMed ID: 21691258 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]